A myth of ophthalmic beta-blockers therapy.
Kittisupamongkol
Weekitt
W
D000058:Accidental Falls / Q000706:statistics & numerical data*; D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001794:Blood Pressure / Q000187:drug effects; D005901:Glaucoma / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000453:epidemiology* / Q000209:etiology; D007429:Intraocular Pressure / Q000187:drug effects; D009798:Ocular Hypertension / Q000188:drug therapy; D009883:Ophthalmic Solutions / Q000008:administration & dosage / Q000009:adverse effects; D018570:Risk Assessment; D011795:Surveys and Questionnaires
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions
BMJ. 2006 Apr 22;332(7547):960-1
16627515
J Am Geriatr Soc. 2001 May;49(5):664-72
11380764
Br Med J. 1956 Jul 21;2(4985):113-6
13329398
Am J Ophthalmol. 2002 Nov;134(5):749-60
12429254
Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1235-41
19452162
J Gerontol A Biol Sci Med Sci. 2004 Dec;59(12):1343-4
15699537
Mayo Clin Proc. 2002 Aug;77(8):839-45; quiz 845-6
12173717